Your browser doesn't support javascript.
loading
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.
Heumann, Philipp; Aguado-Barrera, Miguel E; Avuzzi, Barbara; Azria, David; Briers, Erik; Bultijnck, Renée; Choudhury, Ananya; De Ruysscher, Dirk; Farcy-Jacquet, Marie-Pierre; Fonteyne, Valérie; Gómez Caamaño, Antonio; Helmbold, Irmgard; Johnson, Kerstie; Kerns, Sarah L; Lambrecht, Maarten; Lingard, Zoe; Rancati, Tiziana; Rosenstein, Barry S; Sperk, Elena; Paul Symonds, R; Talbot, Christopher; Valdagni, Riccardo; Vega, Ana; Veldeman, Liv; Ward, Tim; Webb, Adam; West, Catharine M; Chang-Claude, Jenny; Seibold, Petra.
Affiliation
  • Heumann P; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany. Electronic address: philipp.heumann@dkfz.de.
  • Aguado-Barrera ME; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain. Electronic address: miguelelias.aguado@usc.es.
  • Avuzzi B; Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: barbara.avuzzi@istitutotumori.mi.it.
  • Azria D; Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Univ Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France. Electronic address: David.Azria@icm.unicancer.fr.
  • Briers E; Patient advocate, Hasselt, Belgium. Electronic address: erikbriers@telenet.be.
  • Bultijnck R; Ghent University Hospital, Belgium; Ghent University, Ghent, Belgium. Electronic address: Renee.Bultijnck@ugent.be.
  • Choudhury A; University of Manchester, Christie Hospital, Manchester, UK. Electronic address: Ananya.Choudhury@christie.nhs.uk.
  • De Ruysscher D; Maastro Clinic, Maastricht, the Netherlands. Electronic address: dirk.deruysscher@maastro.nl.
  • Farcy-Jacquet MP; Federation Universitaire d'Oncologie Radiothérapie d'Occitanie Méditerranée, Institut du Cancer Du Gard (ICG), CHU Carémeau, Nîmes, France. Electronic address: marie.pierre.farcy.jacquet@chu-nimes.fr.
  • Fonteyne V; Ghent University Hospital, Belgium; Ghent University, Ghent, Belgium. Electronic address: valerie.fonteyne@uzgent.be.
  • Gómez Caamaño A; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain. Electronic address: Antonio.Gomez.Caamano@sergas.es.
  • Helmbold I; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany. Electronic address: i.helmbold@dkfz.de.
  • Johnson K; Department of Genetics & Cancer Sciences, University of Leicester, UK. Electronic address: kerstie@gmail.com.
  • Kerns SL; Medical College of Wisconsin, USA. Electronic address: skerns@mcw.edu.
  • Lambrecht M; KU Leuven, Leuven, Belgium. Electronic address: maarten.lambrecht@uzleuven.be.
  • Lingard Z; University of Manchester, Christie Hospital, Manchester, UK. Electronic address: zoe.lingard@manchester.ac.uk.
  • Rancati T; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: Tiziana.Rancati@istitutotumori.mi.it.
  • Rosenstein BS; The Department of Radiation Oncology and the Department of Genetics & Genomic Sciences, Icahn School of Medicine, New York, USA. Electronic address: barry.rosenstein@mssm.edu.
  • Sperk E; Department of Radiation Oncology, Universitätsmedizin Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: Elena.Sperk@medma.uni-heidelberg.de.
  • Paul Symonds R; Department of Genetics & Cancer Sciences, University of Leicester, UK. Electronic address: rps8@le.ac.uk.
  • Talbot C; Department of Genetics & Cancer Sciences, University of Leicester, UK. Electronic address: cjt14@leicester.ac.uk.
  • Valdagni R; Department of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy. Electronic address: Ricca
  • Vega A; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain; Biomedical Network on Rare Diseases (CIBERER), Spain. Electronic address: ana.vega@usc.es.
  • Veldeman L; Ghent University Hospital, Belgium; Ghent University, Ghent, Belgium. Electronic address: liv.veldeman@uzgent.be.
  • Ward T; UKNCRI CTRad Consumer, UK. Electronic address: timward155@gmail.com.
  • Webb A; Department of Genetics & Cancer Sciences, University of Leicester, UK. Electronic address: ajw51@leicester.ac.uk.
  • West CM; University of Manchester, Christie Hospital, Manchester, UK. Electronic address: Catharine.West@manchester.ac.uk.
  • Chang-Claude J; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany. Electronic address: j.chang-claude@dkfz.de.
  • Seibold P; German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany. Electronic address: p.seibold@dkfz.de.
Radiother Oncol ; 178: 109426, 2023 01.
Article in En | MEDLINE | ID: mdl-36442608
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Urination Disorders Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Urination Disorders Type of study: Diagnostic_studies / Prognostic_studies Aspects: Patient_preference Limits: Humans / Male Language: En Journal: Radiother Oncol Year: 2023 Document type: Article